International Validation of Two Non-motor Scales in PD (NFS and SPARK)

Last updated: April 8, 2025
Sponsor: Insel Gruppe AG, University Hospital Bern
Overall Status: Active - Recruiting

Phase

N/A

Condition

Parkinson's Disease

Dyskinesias

Treatment

N/A

Clinical Study ID

NCT04366804
2020-00303
  • Ages 30-75
  • All Genders

Study Summary

The goal of this project is to develop the international validation of two new rating scales, the Neuropsychiatric Fluctuations Scale (NFS) and the Shame in PARKinson's disease (SPARK) Scale, in order to improve the understanding of the extent and severity of non-motor symptoms in Parkinson's disease (PD).

Eligibility Criteria

Inclusion

Inclusion Criteria:

  1. Written informed consent;

  2. PD, according to the MDS criteria;

  3. Age of participants > 30 and < 75 years;

  4. Being fluent in the language in which the scales are applied.

Exclusion

Exclusion Criteria:

  1. Presence of PD dementia (defined as MoCA score < 24).

Study Design

Total Participants: 300
Study Start date:
December 03, 2020
Estimated Completion Date:
December 31, 2025

Study Description

This project is a prospective international multicentre study to validate two new rating scales in different languages: the Neuropsychiatric Fluctuations Scale (NFS) and the Shame in PARKinson's disease (SPARK) Scale.

The project population consists a minimum of 300 PD patients with and without fluctuations in the participant countries: Spain, Germany, France, Switzerland, Romania and Greece.

The NFS is specifically designed to detect neuropsychiatric fluctuations between off- and on-medication condition in PD. It is composed of 20 items, 10 items measuring the on-neuropsychological symptoms and 10 items for the off-neuropsychological manifestations. The validation of this scale, based on the most frequently experienced symptoms by the patients, would allow a crucial breakthrough in the improvement of management of PD patients.

Shame and embarrassment are poorly recognized by physicians in PD. PD-related shame and embarrassment may emerge from motor and non-motor symptoms, from self-perception of inadequacy due to loss of autonomy and need for help, or from perceived deterioration of body image. The current available scales are not specific for PD. Based on reports of persons affected with PD and a literature review about shame and stigmatization in PD a 25-items self-questionnaire for shame and embarrassment in PD was created. The scale includes 6 different subscales (1. Shame arising from PD symptoms; 2. Shame arising from the increasing physical dependence and need for help induced by PD; 3. Shame arising from the patient's assumption of breaking certain social rules; 4. Shame arising from the deteriorated body image; 5. Consequence of related shame and embarrassment on patients' health-related quality of life; 6. Stigmatization). The validation of this scale will give a tool for physicians and researchers to better understand the impact of PD on patient's quality of life.

Connect with a study center

  • Centre hospitalier régional universitaire de Besançon

    Besançon, 25000
    France

    Active - Recruiting

  • Universitätsklinikum Carl Gustav Carus

    Dresden, 01307
    Germany

    Active - Recruiting

  • Aristotle University of Thessaloniki

    Thessaloniki, 541 24
    Greece

    Active - Recruiting

  • Transilvania University

    Brasov, 500036
    Romania

    Active - Recruiting

  • Hospital Universitario Ramón y Cajal

    Madrid, 28034
    Spain

    Site Not Available

  • Ruber International Hospital

    Madrid, 28034
    Spain

    Active - Recruiting

  • Insel Gruppe AG University Hospital Bern

    Bern, 3010
    Switzerland

    Active - Recruiting

  • King's College London

    London, WC2R 2LS
    United Kingdom

    Site Not Available

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.